ICON Receivables 2010-2024 | ICLR

ICON receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
  • ICON receivables for the quarter ending September 30, 2024 were $1.582B, a 21.46% decline year-over-year.
  • ICON receivables for 2023 were $1.947B, a 5.62% increase from 2022.
  • ICON receivables for 2022 were $1.844B, a 27.18% increase from 2021.
  • ICON receivables for 2021 were $1.45B, a 86.17% increase from 2020.
ICON Annual Receivables
(Millions of US $)
2023 $1,947
2022 $1,844
2021 $1,450
2020 $779
2019 $591
2018 $475
2017 $438
2016 $470
2015 $463
2014 $404
2013 $366
2012 $411
2011 $328
2010 $266
2009 $297
ICON Quarterly Receivables
(Millions of US $)
2024-09-30 $1,582
2024-06-30 $1,727
2024-03-31 $2,015
2023-12-31 $1,947
2023-09-30 $2,014
2023-06-30 $1,958
2023-03-31 $2,003
2022-12-31 $1,844
2022-09-30 $1,537
2022-06-30 $1,473
2022-03-31 $1,484
2021-12-31 $1,450
2021-09-30 $1,437
2021-06-30 $742
2021-03-31 $721
2020-12-31 $779
2020-09-30 $578
2020-06-30 $536
2020-03-31 $583
2019-12-31 $591
2019-09-30 $472
2019-06-30 $503
2019-03-31 $482
2018-12-31 $475
2018-09-30 $433
2018-06-30 $477
2018-03-31 $472
2017-12-31 $438
2017-09-30 $412
2017-06-30 $422
2017-03-31 $399
2016-12-31 $470
2016-09-30 $469
2016-06-30 $431
2016-03-31 $417
2015-12-31 $463
2015-09-30 $433
2015-06-30 $572
2015-03-31 $554
2014-12-31 $404
2014-09-30 $553
2014-06-30 $523
2014-03-31 $467
2013-12-31 $366
2013-09-30 $492
2013-06-30 $476
2013-03-31 $395
2012-12-31 $411
2012-09-30 $345
2012-06-30 $228
2012-03-31 $308
2011-12-31 $328
2011-09-30 $330
2011-06-30 $314
2011-03-31 $310
2010-12-31 $266
2010-09-30 $284
2010-06-30 $257
2010-03-31 $289
2009-12-31 $297
2009-09-30 $318
2009-06-30 $334
2009-03-31 $357
Sector Industry Market Cap Revenue
Medical Medical Services $17.504B $8.120B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
Natera (NTRA) United States $16.570B 0.00
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00